Medical Center – University of Freiburg
Department of Medicine I; Hematology, Oncology and Stem Cell Transplantation
|2016 – present||PhD student in the lab of Prof. Robert Zeiser, Department of Medicine I, Hematology, Oncology and Stem Cell Transplantation, Medical Center - University of Freiburg|
|2014 – 2015||Master of Science (MSc) in Oncology, University of Nottingham, United Kingdom<|
|2011 – 2014||Bachelor of Science (BSc) in Molecular Biology & Genetics, University of East Anglia, United Kingdom|
Shaima’a Hamarsheh, Chitra Joseph, Madeleine Craze, Elena Provenzano, Christopher Nolan, Carlos Caldas, Andrew R. Green, Emad Rakha, Ian O. Ellis, Abhik Mukherjee (2016) High expression of Rsf-1 correlates with poor prognosis in breast cancer, Joint BASO ACS Annual Scientific Conference and NCRI Cancer Conference (Liverpool, United Kingdom)
S Hamarsheh, M Craze, C Joseph, E Provenzano, R Russell, C Caldas, AR Green, E Rakha, IO Ellis, A Mukherjee (2016) Nostrin as a Marker Related to Low Grade and Better Prognosis in Breast Cancer, 9th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland (Nottingham, United Kingdom)
A Mukherjee, R Russell, OM Rueda, S Hamarsheh, C Caldas, E Provenzano, IO Ellis (2016) Exploring Molecular Portraits Defining Low Grade in Breast Cancer, 9th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland (Nottingham, United Kingdom)
Chitra Joseph, Madeleine Craze, Shaima’a Hamarsheh, Ian Ellis, Abhik Mukherjee (2015) HOXB13:IL17BR protein expression ratio in Breast Cancer: Associations with morphology, grade and outcome, NCRI Cancer Conference (Liverpool, United Kingdom)
TT Ha, M Wang, S Hamarsheh, AA Andea (2014) 5-Hydroxymethylcytosine (5hmC) as an Ancillary Aid in the Diagnosis of Melanocytic Lesions, Mod Pathol 27: 129-145; United States & Canadian Academy of Pathology (USCAP) 103rd Annual Meeting (San Diego, California, United States)
Publications based on CRC1160 funding
Hamarsheh, S., O. Gross, T. Brummer, and R. Zeiser. 2020. Immune modulatory effects of oncogenic KRAS in cancer. Nat Commun 11: 5439.
Hamarsheh S, Zeiser R. 2020. NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword. Front Immunol. 8;11:1444. doi: 10.3389/fimmu.2020.01444. eCollection 2020.
Hamarsheh, S., L. Osswald, B. S. Saller, S. Unger, D. De Feo, J. M. Vinnakota, M. Konantz, F. M. Uhl, H. Becker, M. Lubbert, K. Shoumariyeh, C. Schurch, G. Andrieux, N. Venhoff, A. Schmitt-Graeff, S. Duquesne, D. Pfeifer, M. A. Cooper, C. Lengerke, M. Boerries, J. Duyster, C. M. Niemeyer, M. Erlacher, B. R. Blazar, B. Becher, O. Gross, T. Brummer, and R. Zeiser. 2020. Oncogenic Kras(G12D) causes myeloproliferation via NLRP3 inflammasome activation. Nat Commun 11: 1659.